Search results (20)
« Back to News & EventsNew robotic technology to speed up lung cancer diagnosis
20 Aug, 2026
A new robotic-assisted system that supports early and accurate lung cancer diagnosis, while reducing the need for patients to travel long distances, has been unveiled at Oxford University Hospitals NHS Foundation Trust (OUH).
Professor Sarah Blagden shares cutting-edge precision prevention research at Oxford in new Channel 4 Documentary
21 Nov, 2025
Over the past year, Professor Blagden has been filming for Cancer Detectives: Finding the Cures, a new three-part documentary series from Channel 4 which follows three scientists on the front lines of cancer research across the UK.
World’s first lung cancer prevention vaccine gets £2 million for clinical trial
19 Nov, 2025
People at high risk of lung cancer will soon be able to receive the first-ever experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial. The LungVax vaccine carries a series of genetic instructions which train the immune system to recognise tumour antigens on the surface of abnormal lung cells.
Oxford Centre for Cancer Early Detection and Prevention celebrates 5 years at its 2024 Symposium
3 Jan, 2025
On 10-11th December, we celebrated 5 years since the launch of OxCODE with a showcase of Oxford’s most successful cancer early detection and prevention programmes.
Largest ever UK study reveals stark ethnic and social inequalities in lung cancer diagnosis
8 Nov, 2024
Research from Professor Julia Hippisley-Cox shows Bangladeshi men face highest risks, while people in deprived areas are twice as likely to develop lung cancer compared to affluent areas, with important implications for NHS screening.
Oxford lung cancer early detection trial reaches 400 participants
8 Apr, 2024
The SCOOT study seeks current and former smokers across England to provide blood samples for ongoing research aiming to improve lung cancer diagnosis.
£1.7 million for vaccine to prevent lung cancer
22 Mar, 2024
Oxford and UCL researchers seeking to create the world’s first vaccine to prevent lung cancer in people at high risk of the disease have been granted up to £1.7 million from Cancer Research UK and the CRIS Cancer Foundation.
Oxford Centre for Early Cancer Detection Symposium 2023 – a recap
14 Dec, 2023
On Tuesday 5th December, the Oxford early cancer detection community gathered at the Mathematical Institute in Oxford to hear some highlights from OxCODE’s research in the past year and to discuss ideas for future projects.
New tool uses health records to predict risk of developing lung cancer within the next 10 years
6 Apr, 2023
A team of researchers from the University of Oxford and the University of Nottingham have developed ‘CanPredict’, a new tool able to identify those most at risk of developing lung cancer over the next 10 years, and put them forward for screening tests earlier, saving time, money and lives.
Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology
6 Oct, 2022
Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.
Oxford Centre for Early Cancer Detection Symposium 2022 – a recap
4 Oct, 2022
On Tuesday 13th September, the Oxford early cancer detection community gathered at Worcester College to discuss the latest developments in this field, sparking ideas and collaborations for future research.
Cancer at Oxford
29 Sep, 2022
Read about how Oxford's experts are leading the way in cancer prevention, detection and treatment as part of the University's Cancer at Oxford series
Oxford spin-out Optellum attains CE marking for its early lung cancer diagnosis AI technology
5 Apr, 2022
Optellum Virtual Nodule Clinic, including its proprietary artificial intelligence lung cancer prediction solution, has achieved CE certification under the European Union’s Medical Device Regulation.
Understanding AI-based lung nodule risk prediction
21 Mar, 2022
The contribution of individual features on clinical imaging scans to the performance of the LCP-CNN cancer risk prediction model developed in Oxford was investigated.
New partnership for Oxford early cancer detection research spin-out
29 Nov, 2021
Oxford University spin-out Optellum have announced their collaboration with GE Healthcare to advance lung cancer diagnosis using artificial intelligence.
Oxford spin-out partners with Johnson & Johnson to improve lung cancer survival rates
18 Aug, 2021
Optellum, a lung health start-up in Oxford, aims to redefine early interception of lung cancer using artificial intelligence (AI) decision support software.
FDA clearance for Oxford spin-out’s early lung cancer diagnosis software
29 Mar, 2021
Optellum, an Oxford-based lung health company aiming to redefine early diagnosis and treatment of lung disease, has received FDA clearance for its AI-powered clinical decision support software.
CRUK Oxford Centre Symposium 2020
27 Oct, 2020
Oxford’s early detection research is highlighted at this year’s virtual gathering of the Oxford cancer community.
Oxford University to lead a new national programme of AI research to improve lung cancer screening
3 Jul, 2020
UK Research and Innovation, Cancer Research UK and industry are investing more than £11 million in an Oxford-led artificial intelligence (AI) research programme to improve the diagnosis of lung cancer and other thoracic diseases.
External validation of an artificial intelligence tool for predicting malignancy in patients with lung nodules
5 May, 2020
The IDEAL consortium, led by Professor Fergus Gleeson, is working towards the earlier diagnosis of lung cancer.